Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144)

Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144) Publisher Pubmed

Khalighfard S^{1, 2} ; Kalhori MR³ ; Haddad P¹ ; Khori V⁴ ; Alizadeh AM^{2, 5}

Source: European Journal of Pharmacology Published:2024

Abstract

This article has been retracted at the request of Editor-in-Chief. Fig. 5A has been found to contain identical parts to Fig. 2A of an article published in Oncology Letters (Gu et al., 2015 Oncology Letters 9, 1561, 10.3892/ol.2015.2904). The Editor asked the authors for an explanation but a satisfactory answer was not provided. The Editor-in-Chief concluded that they could not vouch for the validity of the data and have decided to retract the article. © 2024 Elsevier B.V.

Related Docs

View other Related Docs

1. Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144] (European Journal of Pharmacology (1998) 342(1) (67–76), (S0014299997014179), (10.1016/S0014-2999(97)01417-9)), European Journal of Pharmacology (2024)

2. Retraction Notice to “The Therapeutic Potential of Human Adipose-Derived Mesenchymal Stem Cells Producing Cxcl10 in a Mouse Melanoma Lung Metastasis Model” [Cancer Lett. 419 (2018) 30–39, (S030438351830051x), (10.1016/J.Canlet.2018.01.029)], Cancer Letters (2024)

3. Retraction Notice to “Inhibition of Hif-1Α/Ep4 Axis by Hyaluronate-Trimethyl Chitosan-Spion Nanoparticles Markedly Suppresses the Growth and Development of Cancer Cells” [Int. J. Biol. Macromol. 167 (2021) 1006–1019, (S0141813020349801), (10.1016/J.Ijbiomac.2020.11.056)], International Journal of Biological Macromolecules (2025)

Experts (# of related papers)

View all Related Experts

Mansoureh Togha (1)

Alimohammad Alizadeh (1)

Style	Citing Format
MLA	Khalighfard S, et al.. "Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144)." European Journal of Pharmacology, vol. 969, no. , 2024, pp. -.
APA	Khalighfard S, Kalhori MR, Haddad P, Khori V, Alizadeh AM (2024). Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144). European Journal of Pharmacology, 969(), -.
Chicago	Khalighfard S, Kalhori MR, Haddad P, Khori V, Alizadeh AM. "Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144)." European Journal of Pharmacology 969, no. (2024): -.
Harvard	Khalighfard S et al. (2024) 'Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144)', European Journal of Pharmacology, 969(), pp. -.
Vancouver	Khalighfard S, Kalhori MR, Haddad P, Khori V, Alizadeh AM. Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144). European Journal of Pharmacology. 2024;969():-.
BibTex	@article{ author = {Khalighfard S and Kalhori MR and Haddad P and Khori V and Alizadeh AM}, title = {Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144)}, journal = {European Journal of Pharmacology}, volume = {969}, number = {}, pages = {-}, year = {2024} }
RIS	TY - JOUR AU - Khalighfard S AU - Kalhori MR AU - Haddad P AU - Khori V AU - Alizadeh AM TI - Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144) JO - European Journal of Pharmacology VL - 969 IS - SP - EP - PY - 2024 ER -

Style

Citing Format

MLA

Khalighfard S, et al.. "Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144)." European Journal of Pharmacology, vol. 969, no. , 2024, pp. -.

APA

Khalighfard S, Kalhori MR, Haddad P, Khori V, Alizadeh AM (2024). Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144). European Journal of Pharmacology, 969(), -.

Chicago

Khalighfard S, Kalhori MR, Haddad P, Khori V, Alizadeh AM. "Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144)." European Journal of Pharmacology 969, no. (2024): -.

Harvard

Khalighfard S et al. (2024) 'Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144)', European Journal of Pharmacology, 969(), pp. -.

Vancouver

Khalighfard S, Kalhori MR, Haddad P, Khori V, Alizadeh AM. Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144). European Journal of Pharmacology. 2024;969():-.

BibTex

@article{ author = {Khalighfard S and Kalhori MR and Haddad P and Khori V and Alizadeh AM}, title = {Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144)}, journal = {European Journal of Pharmacology}, volume = {969}, number = {}, pages = {-}, year = {2024} }

RIS

TY - JOUR
AU - Khalighfard S
AU - Kalhori MR
AU - Haddad P
AU - Khori V
AU - Alizadeh AM
TI - Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144)
JO - European Journal of Pharmacology
VL - 969
IS -
SP -
EP -
PY - 2024
ER -

Science Communicator Platform

Authors

Abstract